Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis.

Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Engh ME, Oddenes K, Rokne JA, Tjugum J, Lode MS, Amant F, Salvesen HB.

Eur J Cancer. 2013 Feb;49(3):625-32. doi: 10.1016/j.ejca.2012.09.006. Epub 2012 Oct 1.

PMID:
23036850
2.

Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.

Trovik J, Wik E, Werner HM, Krakstad C, Helland H, Vandenput I, Njolstad TS, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC; MoMaTEC study group, Amant F, Akslen LA, Salvesen HB.

Eur J Cancer. 2013 Nov;49(16):3431-41. doi: 10.1016/j.ejca.2013.06.016. Epub 2013 Aug 8.

3.

Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.

Lajer H, Elnegaard S, Christensen RD, Ortoft G, Schledermann DE, Mogensen O.

Acta Obstet Gynecol Scand. 2012 Aug;91(8):976-82. doi: 10.1111/j.1600-0412.2012.01438.x. Epub 2012 Jun 18.

PMID:
22548255
4.

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.

Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT.

Gynecol Oncol. 2006 Jul;102(1):92-7. Epub 2006 Jan 10.

PMID:
16406063
5.

Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.

Chen YL, Huang CY, Chien TY, Huang SH, Wu CJ, Ho CM.

Aust N Z J Obstet Gynaecol. 2011 Oct;51(5):397-402. doi: 10.1111/j.1479-828X.2011.01325.x. Epub 2011 Jun 9.

PMID:
21806586
6.

Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.

Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, Njolstad TS; MoMaTec Study Group, Vandenput I, Amant F, Akslen LA, Salvesen HB.

Clin Cancer Res. 2011 May 15;17(10):3368-77. doi: 10.1158/1078-0432.CCR-10-2412. Epub 2011 Jan 17.

7.

Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study.

Kang S, Kang WD, Chung HH, Jeong DH, Seo SS, Lee JM, Lee JK, Kim JW, Kim SM, Park SY, Kim KT.

J Clin Oncol. 2012 Apr 20;30(12):1329-34. doi: 10.1200/JCO.2011.38.2416. Epub 2012 Mar 12.

8.

Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.

Helpman L, Kupets R, Covens A, Saad RS, Khalifa MA, Ismiil N, Ghorab Z, Dubé V, Nofech-Mozes S.

Br J Cancer. 2014 Feb 4;110(3):609-15. doi: 10.1038/bjc.2013.766. Epub 2013 Dec 24.

9.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
10.

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C.

J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.

11.

Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.

Ben Arie A, Lavie O, Gdalevich M, Voldarsky M, Barak F, Schneider D, Levy T, Anteby E, Gemer O.

Eur J Surg Oncol. 2012 Feb;38(2):166-9. doi: 10.1016/j.ejso.2011.10.011. Epub 2011 Nov 6.

PMID:
22056646
12.
13.

Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases.

van Doorn HC, van der Zee AG, Peeters PH, Kroeks MV, van Eijkeren MA.

Int J Gynecol Cancer. 2002 Mar-Apr;12(2):144-8.

PMID:
11975673
14.

Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.

Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F, Salvesen HB; MoMaTEC study group.

Gynecol Oncol. 2012 Apr;125(1):103-8. doi: 10.1016/j.ygyno.2011.11.008. Epub 2011 Nov 17.

PMID:
22100838
15.

The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.

Vance S, Yechieli R, Cogan C, Hanna R, Munkarah A, Elshaikh MA.

Gynecol Oncol. 2012 Jul;126(1):16-9. doi: 10.1016/j.ygyno.2012.04.011. Epub 2012 Apr 13.

PMID:
22507535
16.

Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.

Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP.

Acta Obstet Gynecol Scand. 2006;85(12):1501-5.

PMID:
17260229
18.

The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer.

Sawicki W, Spiewankiewicz B, Stelmachów J, Cendrowski K.

Eur J Gynaecol Oncol. 2003;24(3-4):293-8.

PMID:
12807243
19.

[Synchronous primary cancers of the endometrium and ovary: review of 43 cases].

Ma SK, Zhang HT, Sun YC, Wu LY.

Zhonghua Zhong Liu Za Zhi. 2008 Sep;30(9):690-4. Chinese.

PMID:
19173912
20.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
Items per page

Supplemental Content

Write to the Help Desk